INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 149 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,619,000 | -21.5% | 129,878 | -5.8% | 0.38% | -12.4% |
| Q2 2019 | $10,973,000 | -11.5% | 137,898 | +24.4% | 0.44% | -12.3% |
| Q1 2019 | $12,396,000 | +83.4% | 110,818 | -4.2% | 0.50% | +84.8% |
| Q4 2017 | $6,758,000 | -5.3% | 115,679 | +76.2% | 0.27% | -20.9% |
| Q4 2016 | $7,133,000 | -31.5% | 65,654 | +3.8% | 0.34% | -35.8% |
| Q3 2016 | $10,408,000 | +75.8% | 63,233 | +52.4% | 0.53% | +59.6% |
| Q2 2016 | $5,920,000 | +163.8% | 41,491 | +137.5% | 0.33% | +163.5% |
| Q1 2016 | $2,244,000 | -43.1% | 17,470 | -33.8% | 0.13% | -39.4% |
| Q4 2015 | $3,943,000 | -48.1% | 26,400 | -42.4% | 0.21% | -58.1% |
| Q3 2015 | $7,600,000 | -8.4% | 45,820 | +33.3% | 0.50% | -22.5% |
| Q2 2015 | $8,295,000 | -20.0% | 34,364 | -11.4% | 0.64% | -24.6% |
| Q1 2015 | $10,367,000 | +65.2% | 38,799 | -3.5% | 0.85% | +56.0% |
| Q4 2014 | $6,275,000 | +63.2% | 40,227 | +147.6% | 0.54% | +54.4% |
| Q2 2014 | $3,845,000 | -56.5% | 16,248 | -39.4% | 0.35% | -58.3% |
| Q1 2014 | $8,845,000 | -22.2% | 26,821 | -73.4% | 0.85% | +24.6% |
| Q4 2013 | $11,368,000 | -9.1% | 100,717 | -44.4% | 0.68% | -21.4% |
| Q3 2013 | $12,506,000 | +1087.7% | 181,162 | +671.7% | 0.86% | +385.4% |
| Q2 2013 | $1,053,000 | – | 23,476 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |